PuSH - Publication Server of Helmholtz Zentrum München

Aretz, J.* ; Aziz, M. ; Strohmeyer, N.* ; Sattler, M. ; Fässler, R.*

Talin and kindlin use integrin tail allostery and direct binding to activate integrins.

Nat. Struct. Mol. Biol. 30, 1913-1924 (2023)
Publ. Version/Full Text DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Integrin affinity regulation, also termed integrin activation, is essential for metazoan life. Although talin and kindlin binding to the β-integrin cytoplasmic tail is indispensable for integrin activation, it is unknown how they achieve this function. By combining NMR, biochemistry and cell biology techniques, we found that talin and kindlin binding to the β-tail can induce a conformational change that increases talin affinity and decreases kindlin affinity toward it. We also discovered that this asymmetric affinity regulation is accompanied by a direct interaction between talin and kindlin, which promotes simultaneous binding of talin and kindlin to β-tails. Disrupting allosteric communication between the β-tail-binding sites of talin and kindlin or their direct interaction in cells severely compromised integrin functions. These data show how talin and kindlin cooperate to generate a small but critical population of ternary talin-β-integrin-kindlin complexes with high talin-integrin affinity and high dynamics.
Impact Factor
Scopus SNIP
Altmetric
16.800
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Structural Basis; Adhesion Measurements; Domain; Complexes; Reveals
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 1545-9993
e-ISSN 1545-9985
Quellenangaben Volume: 30, Issue: 12, Pages: 1913-1924 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place New York, NY
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503000-001
Grants Max Planck Society
Swiss National Science Foundation
DFG
European Research Council
Scopus ID 85179645416
PubMed ID 38087085
Erfassungsdatum 2023-12-20